The platinum drugs most effective in treating ovarian cancer are in limited supply due to the drug shortage; the government proposes a plan to prevent hospitals from redistributing Medicaid money; physicians ask for help in treating the high number of children with mental illness coming to the emergency department.
Patients with ovarian cancer are among the groups most affected by the drug shortages as the most effective platinum drugs carboplatin and cisplatin are in limited supply, according to Stat News. Both drugs have been hard to keep stocked for months in most cancer centers, as 93% reported carboplatin shortages and 70% reported cisplatin shortages. Although there are alternatives to platinum drugs in ovarian cancer treatment, none work as well as carboplatin in combination with the chemotherapy drug paclitaxel, especially when the treatment could be curative. Patients have described a significant physical and emotional toll from needing to use less-than-optimal alternatives.
The Biden administration may punish hospitals violating federal law by making private arrangements to reimburse themselves for taxes that help fund coverage for low-income patients, according to KFF Health News. Federal regulators explained that hospitals disregarded the proposed enforcement plan released May 3 by CMS that designated the money for facilities treating low-income patients, instead redirecting it to ones that provide little to no Medicaid-covered services. The government’s most recent proposal against this secret but widespread practice requires states to monitor the use of Medicaid money in hospitals, nursing homes, and other health care providers to make sure it is not redistributed. However, some Medicaid experts predict this plan could fail or face immediate challenges in court if adopted.
Emergency medicine providers and pediatricians pleaded for additional support and resources due to the number of children and teenagers with mental health concerns presenting to emergency departments nationwide, according to NBC News. The article covered a joint policy statement from the American College of Emergency Physicians, the American Academy of Pediatrics, and the Emergency Nurses Association released Wednesday. In the statement, the groups call for increased access to mental health services in local communities to prevent the need for emergency care. Although emergency physicians can address mental health issues at the surface level, the groups write, they typically do not have the resources to do so over long periods.
High HSP60 Expression Signals Poor Prognosis, Aggressive Tumors in Ovarian Cancer
January 16th 2025High heat shock protein 60 (HSP60) expression in patients with ovarian cancer is associated with larger tumors, advanced stages, and worse survival outcomes, highlighting its potential as a prognostic biomarker.
Read More
Niraparib Improves Outcomes in Patients With Stage III EOC, No Visible Residual Disease
January 14th 2025Patients with stage III epithelial ovarian cancer (EOC) and no visible residual disease after primary cytoreductive surgery had significantly longer real-world progression-free survival and time to next treatment when treated with first-line maintenance niraparib compared with those with higher-risk disease.
Read More
Nomogram Predicts Overall Survival in Patients With Ovarian Cancer, Liver Metastases
January 9th 2025Researchers developed and validated a nomogram to predict 1-, 2-, and 3-year overall survival (OS) in patients with ovarian cancer and liver metastases (OCLM), outperforming an external model in stability and accuracy.
Read More
Global Trends in Ovarian Cancer Incidence Highlight Regional, Histological Variations
January 7th 2025Between 1988 and 2017, there were significant global variations and trends in ovarian cancer incidence and its subtypes, influenced by genetic, reproductive, and socioeconomic factors.
Read More
Top 5 Most-Read Ovarian Cancer Content of 2024
December 29th 2024The top 5 ovarian cancer articles of 2024 covered topics such as the impact of air pollution on ovarian cancer risk, treatment strategies for patients with liver metastases, and the benefits of early diagnosis through symptom-triggered testing.
Read More
Exercise May Benefit Chemotherapy-Induced Peripheral Neuropathy in Patients With Ovarian Cancer
December 23rd 2024Exercise interventions may help manage chemotherapy-induced peripheral neuropathy (CIPN) in patients with ovarian cancer through improved physical activity and muscle function, but evidence remains limited.
Read More